To determine the influence of dynamic light conditions on visual functioning in glaucoma. For this purpose we measure (1) the contrast sensitivity to a small stimuli at a time-varying background luminance and (2) the critical fusion frequency (CFF…
ID
Source
Brief title
Condition
- Glaucoma and ocular hypertension
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Contrast gain control as a function of the frequence in which background
luminance changes in time. Contrast sensitivity in central and peripheral sites
of the retina will be measured by using a staircase method. The contrast gain
control will be defined as the difference between the contrast sensitivity
measured at static (0 Hz) versus the dynamic light conditions. The contrast
gain control can then be compared between the healthy control group and
glaucoma patients. We measure contrast gain control at two different values of
the mean background luminance and for two polarities (white (increment) and
black (decrement) stimuli on a gray background).
Secondary outcome
Critical Fusion Frequency (CFF). CFF is the highest frequency at which flicker
can be detected. This will be measured in the central and peripheral visual
field for a range of background luminances.
Background summary
Glaucoma is an optic neuropathy in which a degeneration of retinal ganglion
cells results in loss of the visual field and - if left untreated - blindness.
Recent studies have uncovered that significant visual complaints exist even if
the visual field is still intact or only mildly affected. These complaints are
related to light and dark adaptation.
The human retina can adjust its operating range to a wide range of illumination
levels. Adaptation refers to both the process of adjustment, that is, adapting
to a new condition, and to be adapted to a condition. Previous studies have
uncovered that adaptation to different light conditions is disturbed in
glaucoma: it is delayed and incomplete.
We aim to extend this research and to determine how patients with glaucoma
perform under rapidly varying light conditions. For this purpose we will
perform psychophysical experiments with a stimuli presented on a computer
screen where either the background luminance or the stimulus itself changes
rapidly with time. The former paradigm refers to contrast gain control (the
retina*s ability to keep its sensitivity in the presence of changing
contrasts); the latter is known as flicker sensitivity.
The measurements will be performed by glaucoma patients (n = 30) and healthy
subjects (n = 30) (see 4.4 Sample Size Calculation). By comparing the results
for each patient with data from normal observers, we will determine the extent
of the visual losses associated with glaucoma, thus yielding new insights of
light adaptation dynamics in glaucoma. Subjects with glaucoma will be recruited
from a population of glaucoma patients who visit the ophthalmology clinic at
the University Medical Center Groningen. For the recruitment of healthy
subjects, poster adverts (see Appendix E3) will be placed in and around the
UMCG
Study objective
To determine the influence of dynamic light conditions on visual functioning in
glaucoma. For this purpose we measure (1) the contrast sensitivity to a small
stimuli at a time-varying background luminance and (2) the critical fusion
frequency (CFF), which is the highest frequency of flicker that can be
distinguished from steady state (temporal sensitivity).
Study design
Case-control study
Study burden and risks
Patients and healthy subjects will have one visit to the Laboratory of
Experimental Ophthalmology to perform psychophysical experiments . Healthy
subjects will undergo screening to assess their eye health, which will comprise
a questionnaire (see Appendix F1), letter chart, visual field test, optical
coherence tomography (OCT) test of retina and optic nerve head, and intraocular
pressure (IOP) measurement. Screening will take around 20 minutes. The eye will
not be touched during screening, nor are mydriatic drugs required for pupil
dilation. If abnormal screening results are obtained for healthy subjects, they
will be referred to their GP. Dtection of an eye condition may cause
psychological stress, however, an early diagnosis will allow treatments to be
initiated and therefore more preservation of visual functioning. Glaucoma
patients will not perform any screening tests, therefore there is no risk of
ientifying any other eye conditions. Subjects with glaucoma will be recruited
froam a population of glaucoma patients who visit the ophthalmology clinic at
the UMCG. For the recruitment of healthy subjects, poster adverts (see Appendix
E3) will be placed in and around the UMCG. Patients and healthy subjects will
spend 1.5 and 2 hours in our lab, respectively, to complete the required tasks.
Hanzeplein 1 N/A
Groningen 9700 RB
NL
Hanzeplein 1 N/A
Groningen 9700 RB
NL
Listed location countries
Age
Inclusion criteria
Glaucoma patients between ages 50 and 75, who visit the Ophthalmology clinic at University Medical Center Groningen, that have provided the informed consent form and meet the inclusion-exclusion criteria.
Healthy subjects between ages 50 and 75, who have provided the informed consent form and returned the questionnaire with results which do not indicate ophthalmic abnormalities.
Exclusion criteria
Glaucoma Patients:
Visual acuity less than 0.8
Non-glaucomatous visual field loss;Healthy Subjects:
Visual acuity less than 0.8
Any visual field loss
Intraocular pressure above 21 mmHg
Positive family history of glaucoma
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
Register | ID |
---|---|
Other | n/a |
CCMO | NL61403.042.17 |
OMON | NL-OMON29472 |